Diaceutics
Diaceutics Receives CMS Approval for Increased Data Access
The data it receives will be integrated into Diaceutics' DXRX diagnostic platform to provide additional insight into the testing landscape.
EU IVDR Implementation Woes Could Severely Limit Cancer Companion Test, Precision Therapy Access
Premium
The EC has stuck with its timeline to implement the new regulations in eight months, raising concerns for cancer patients' ability to receive biomarker testing and treatments.
LGC SeraCare Joins Diaceutics DXRX Network for Precision Medicine Diagnostics
The partnership will introduce additional types of test reference materials to users of the platform, including the Seraseq FFPE Tumor Fusion RNA Reference Material v4.
Diaceutics, Alva10 Gathering Evidence Base for Improving PD-L1 Test Reimbursement
The companies will work with labs to improve payors' understanding of the costs of performing PD-L1 testing and the value it provides to patient care.
With New Partnerships, Diaceutics Works to Standardize CDx Testing Globally
The deals with three quality assessment organizations will contribute to the firm's goal of connecting pharmaceutical companies, diagnostic firms, and laboratories.